FFAR4
MOLECULAR TARGETfree fatty acid receptor 4
FFAR4 (free fatty acid receptor 4) is targeted by 7 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting FFAR4
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | gw9508 | 3.00 | 19 |
| 2 | alpha-Linolenic Acid | 1.39 | 3 |
| 3 | Linoleic Acid | 1.10 | 2 |
| 4 | Oleic Acid | 0.69 | 1 |
| 5 | Dihydroergotamine | 0.69 | 1 |
| 6 | Myristic Acid | 0.69 | 1 |
| 7 | Tolterodine Tartrate | 0.69 | 1 |
About FFAR4 as a Drug Target
FFAR4 (free fatty acid receptor 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 7 compounds with documented FFAR4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
FFAR4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.